Justina Petrullo

Sexual and gender minority patients with chronic inflammatory skin diseases may be disproportionately influenced by cost and noncost obstacles to health care.

When combining adalimumab with surgery, patient outcomes, including quality of life, were improved.

While some resistance was noted against azithromycin, clindamycin, and erythromycin, they were not statistically significant.

Changes to skin and nerve endings as a result of HS may contribute to peripheral neuropathy.

Female sex bias in hidradenitis suppurativa can be attributed to several contributing immunological factors.

Genetic variants associated with hidradenitis suppurativa (HS) were identified, although a causal effect is not proven.

More understanding of the physical, psychological, and economic burdens of hyperhidrosis is needed.

An anonymous, online survey was conducted through HS support groups from June 2022 to July 2022.

It was found that cancer treatment, pediatric population, and coverage restriction of reference products were revealed as some of the strongest factors associated with biosimilar coverage decisions by US commercial health plans relative to reference products.